Back to
Geode Capital Management, LLC
AGRX
3 quarters
Position history for
Geode Capital Management, LLC's holdings in AGILE THERAPEUTICS INC
No. Geode Capital Management exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 13,748 shares worth $26,808. Geode Capital Management first reported AGRX in Q3 2023 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$33,233
Total Shares Change
-13,790
Quarter-by-Quarter History
Other major holders of AGRX: Renaissance Technologies LLC, Citadel Advisors LLC, State Street Corp.